The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China

The pandemic outbreak of coronavirus disease 2019 (COVID-19) is rapidly spreading all over the world. Reports from China showed that about 20% of patients developed severe disease, resulting in a fatality of 4%. In the past two months, we clinical immunologists participated in multi-rounds of MDT (m...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Immunol
Autori principali: Zhang, Wen, Zhao, Yan, Zhang, Fengchun, Wang, Qian, Li, Taisheng, Liu, Zhengyin, Wang, Jinglan, Qin, Yan, Zhang, Xuan, Yan, Xiaowei, Zeng, Xiaofeng, Zhang, Shuyang
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier Inc. 2020
Soggetti:
Review Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7102614/
https://ncbi.nlm.nih.gov/pubmed/32222466
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clim.2020.108393
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi